Dr Sulaiman Al-Habib Medical Services Group Co
SAU:4013

Watchlist Manager
Dr Sulaiman Al-Habib Medical Services Group Co Logo
Dr Sulaiman Al-Habib Medical Services Group Co
SAU:4013
Watchlist
Price: 280 SAR -0.5% Market Closed
Market Cap: 98B SAR
Have any thoughts about
Dr Sulaiman Al-Habib Medical Services Group Co?
Write Note

Net Margin
Dr Sulaiman Al-Habib Medical Services Group Co

21.7%
Current
20%
Average
2.2%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
21.7%
=
Net Income
2.2B
/
Revenue
10B

Net Margin Across Competitors

Country SA
Market Cap 98B SAR
Net Margin
22%
Country US
Market Cap 83.9B USD
Net Margin
9%
Country ZA
Market Cap 24.9B Zac
Net Margin
17%
Country ZA
Market Cap 20.7B Zac
Net Margin
5%
Country CN
Market Cap 133.2B CNY
Net Margin
18%
Country MY
Market Cap 63.3B MYR
Net Margin
11%
Country US
Market Cap 13.7B USD
Net Margin
15%
Country US
Market Cap 13.1B USD
Net Margin
7%
Country TH
Market Cap 421.1B THB
Net Margin
15%
Country IN
Market Cap 997.2B INR
Net Margin
5%
Country IN
Market Cap 971.9B INR
Net Margin
19%
No Stocks Found

Dr Sulaiman Al-Habib Medical Services Group Co
Glance View

Market Cap
98B SAR
Industry
Health Care

Dr. Sulaiman Al-Habib Medical Services Group Co. (HMG) has emerged as a beacon of healthcare excellence in the Middle East, rooted deeply in a commitment to enhancing patient care. Founded in 1995 by Dr. Sulaiman Al-Habib, the company has grown from a singular hospital in Riyadh to a sprawling network of advanced medical facilities across Saudi Arabia and the region. With a mission to deliver high-quality medical services, HMG operates multiple hospitals, clinics, and specialized centers, ensuring that a diverse array of healthcare needs—from routine check-ups to complex surgeries—are met with state-of-the-art technology and skilled practitioners. The company’s dedication to continuous improvement is evident in its robust investment in research and development, alongside strategic partnerships that enhance its medical offerings. For investors, HMG represents a compelling opportunity within the booming healthcare sector. As the demand for quality medical services rises—fueled by a growing population and a heightened focus on health—HMG's established reputation and expansive market presence position it favorably for continued growth. The group's financial stability, underpinned by innovative healthcare solutions and a strong brand, highlights its potential for profitability in the years to come. With a vision to lead in integrated healthcare services, Dr. Sulaiman Al-Habib Medical Services Group Co. not only stands out for its operational excellence but also offers investors the chance to be part of a transformative journey in the healthcare landscape of the Middle East.

Intrinsic Value
197.1 SAR
Overvaluation 30%
Intrinsic Value
Price

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
21.7%
=
Net Income
2.2B
/
Revenue
10B
What is the Net Margin of Dr Sulaiman Al-Habib Medical Services Group Co?

Based on Dr Sulaiman Al-Habib Medical Services Group Co's most recent financial statements, the company has Net Margin of 21.7%.